Association of robotic-assisted vs laparoscopic radical nephrectomy with perioperative outcomes and health care costs, 2003 to 2015

JAMA - Journal of the American Medical Association

Volumn 318, Issue 16, 2017, Pages 1561-1568

  Jeong, In Gab ^a,b   Khandwala, Yash S ^a,c   Kim, Jae Heon ^a   Han, Deok Hyun ^a   Li, Shufeng ^a   Wang, Ye ^d   Chang, Steven L ^d   Chung, Benjamin I ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b University of Ulsan College of Medicine   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLAVIEN CLASSIFICATION SYSTEM; COHORT ANALYSIS; COMORBIDITY; ELECTIVE SURGERY; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL COST; HUMAN; INTERMETHOD COMPARISON; KIDNEY TUMOR; LAPAROSCOPIC SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPERATION DURATION; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADICAL NEPHRECTOMY; RETROSPECTIVE STUDY; ROBOT ASSISTED SURGERY; SCORING SYSTEM; TREND STUDY; UNITED STATES; COMPARATIVE STUDY; ECONOMICS; KIDNEY DISEASES; LAPAROSCOPY; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; ROBOTIC SURGICAL PROCEDURE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRENDS;

AGED; FEMALE; HOSPITAL COSTS; HUMANS; KIDNEY DISEASES; LAPAROSCOPY; LOGISTIC MODELS; MALE; MIDDLE AGED; NEPHRECTOMY; OPERATIVE TIME; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; ROBOTIC SURGICAL PROCEDURES; UNITED STATES;

EID: 85032635362     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.14586     Document Type: Article

References (40)

1. Van Poppel H, Becker F, Cadeddu JA, et al. Treatment of localised renal cell carcinoma. Eur Urol. 2011;60(4):662-672.
2. Dunn MD, Portis AJ, Shalhav AL, et al. Laparoscopic versus open radical nephrectomy: A 9-year experience. J Urol. 2000;164(4):1153-1159.
3. Permpongkosol S, Chan DY, Link RE, et al. Longterm survival analysis after laparoscopic radical nephrectomy. J Urol. 2005;174(4 pt 1):1222-1225.
4. Schiavone MB, Kuo EC, NaumannRW, et al. The commercialization of robotic surgery:unsubstantiated marketing of gynecologic surgery by hospitals. AmJ Obstet Gynecol. 2012;207(3):174.e1-174.e7.
5. Wright JD, Tergas AI, Hou JY, et al. Effect of regional hospital competition and hospital financial status on the use of robotic-assisted surgery. JAMA Surg. 2016;151(7):612-620.
6. Leow JJ, Chang SL, Meyer CP, et al. Robot-assisted versus open radical prostatectomy: A contemporary analysis of an all-payer discharge database. Eur Urol. 2016;70(5):837-845.
7. Barbash GI, Glied SA. New technology and health care costs-the case of robot-assisted surgery. N Engl J Med. 2010;363(8):701-704.
8. Wright JD, Burke WM, Wilde ET, et al. Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. J Clin Oncol. 2012;30(8):783-791.
9. Breitenstein S, Nocito A, Puhan M, Held U, Weber M, Clavien PA. Robotic-assisted versus laparoscopic cholecystectomy: Outcome and cost analyses of a case-matched control study. Ann Surg. 2008;247(6):987-993.
10. Paul S, McCulloch P, Sedrakyan A. Robotic surgery: Revisiting "no innovation without evaluation". BMJ. 2013;346:f1573.
11. Asimakopoulos AD, Miano R, Annino F, et al. Robotic radical nephrectomy for renal cell carcinoma: A systematic review. BMC Urol. 2014;14:75.
12. Hemal AK, Kumar A. A prospective comparison of laparoscopic and robotic radical nephrectomy for T1-2N0M0 renal cell carcinoma. World J Urol. 2009;27(1):89-94.
13. Weinberg AC, Whalen MJ, Paulucci DJ, et al. Utilization of the robotic surgical platform for radical nephrectomy: A national comparison of trends for open, laparoscopic and robotic approaches. Urol Pract. 2016;3(3):187-194.
14. Golombos DM, Chughtai B, Trinh QD, et al. Adoption of technology and its impact on nephrectomy outcomes, a US population-based analysis (2008-2012). J Endourol. 2017;31(1):91-99.
15. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med. 2008;358 (8):771-783.
16. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4): 349-361.
17. Wright JD, Ananth CV, Lewin SN, et al. Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA. 2013;309(7):689-698.
18. Leow JJ, Chang SL, Trinh QD. Accurately determining patients who underwent robot-assisted surgery: Limitations of administrative databases. BJU Int. 2016;118(3):346-348.
19. Tinay I, Gelpi-Hammerschmidt F, LeowJJ, et al. Trendsin utilisation, perioperativeoutcomes, andcosts of nephroureterectomies inthemanagementofupper tract urothelial carcinoma: A 10-year population-based analysis. BJU Int. 2016;117(6):954-960.
20. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205-213.
21. LeowJJ, Reese SW, JiangW, et al. Propensitymatched comparison of morbidity and costs of open and robot-assisted radical cystectomies: A contemporary population-based analysis in the United States. Eur Urol. 2014;66(3):569-576.
22. Gastmeier P, Sohr D, Breier A, BehnkeM, Geffers C. Prolonged duration of operation: An indicator of complicated surgery or of surgical (mis)management?. Infection. 2011;39(3):211-215.
23. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303(23):2359-2367.
24. Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA. 2010;303(20):2035-2042.
25. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011; 46(3):399-424.
26. Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY. Methods for analyzing health care utilization and costs. Annu Rev Public Health. 1999;20:125-144.
27. Patel HD, Mullins JK, Pierorazio PM, et al. Trends in renal surgery: Robotic technology is associated with increased use of partial nephrectomy. J Urol. 2013;189(4):1229-1235.
28. Intuitive Surgical. Intuitive surgical investment presentation Q3 2017. http://phx.corporate-ir.net /phoenix.zhtml?c=122359&p=irol-irhome. Updated August 4, 2017. Accessed August 18, 2017.
29. Ramsay C, Pickard R, Robertson C, et al. Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health Technol Assess. 2012;16(41):1-313.
30. Ghani KR, Sukumar S, Sammon JD, Rogers CG, Trinh QD, Menon M. Practice patterns and outcomes of open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: Results from the nationwide inpatient sample. J Urol. 2014;191(4):907-912.
31. Kara Ö, Maurice MJ, Mouracade P, et al. When partial nephrectomy is unsuccessful: Understanding the reasons for conversion from robotic partial to radical nephrectomy at a tertiary referral center. J Urol. 2017;198(1):30-35.
32. Khandwala YS, Jeong IG, Kim JH, et al. The incidence of unsuccessful partial nephrectomy within the United States: A nationwide population-based analysis from 2003 to 2015. Urol Oncol. 2017;S1078-1439(17)30424-6.
33. KatesM, BallMW, Patel HD, Gorin MA, Pierorazio PM, Allaf ME. The financial impact of robotic technology for partial and radical nephrectomy. J Endourol. 2015;29(3):317-322.
34. Venkat P, Chen LM, Young-Lin N, et al. An economic analysis of robotic versus laparoscopic surgery for endometrial cancer: Costs, charges and reimbursements to hospitals and professionals. Gynecol Oncol. 2012;125(1):237-240.
35. Centers for Medicare & Medicaid Services. Acute care hospital inpatient prospective payment system: Payment system series. https://www.cms .gov/Outreach-and-Education/Medicare-Learning -Network-MLN/MLNProducts/downloads /AcutePaymtSysfctsht.pdf. Published December 2016. Accessed 25 August 2017.
36. McCarthyM. Some US hospitals charge 10 times the cost of services, study finds. BMJ. 2015;350:h3285.
37. Bai G, Anderson GF. Extreme markup: The fifty us hospitals with the highest charge-to-cost ratios. Health Aff (Millwood). 2015;34(6):922-928.
38. Ederhof M, Ginsburg PB. Improving hospital incentives with better cost data. N Engl J Med. 2017; 376(11):1010-1011.
39. Chopra S, Simone G, Metcalfe C, et al. Robot-assisted level II-III inferior vena cava tumor thrombectomy: Step-by-step technique and 1-year outcomes. Eur Urol. 2017;72(2):267-274.
40. Breda A, Finelli A, Janetschek G, Porpiglia F, Montorsi F. Complications of laparoscopic surgery for renal masses: Prevention, management, and comparison with the open experience. Eur Urol. 2009;55(4):836-850.